MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    GASTROINTESTINAL SYMPTOMS ARE ASSOCIATED WITH LEFT PREDOMINANT DOPAMINE TRANSPORTER BINDING DEFICIT IN PARKINSON´S DISEASE

    K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, R. Levo, T. Nojonen, M. Eklund, S. Nuuttila, K. Lindholm, E. Pekkonen, J. Joutsa, T. Noponen, T. Ihalainen, V. Kaasinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess correlations between functional gastrointestinal (GI) symptoms and nigrostriatal dopamine transporter imaging asymmetry in Parkinson´s disease (PD) patients. Based on a theory that…
  • MDS Virtual Congress 2021

    Peripheral neuromodulation for the treatment of bladder symptoms associated with Parkinson’s disease

    M. Smith, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To undertake a systematic review of the literature on peripheral neuromodulation techniques for the treatment of bladder symptoms in Parkinson’s disease (PD). Background: Bladder…
  • MDS Virtual Congress 2021

    Evidence of gut dysbiosis in treatment-naïve de novo Parkinson’s disease

    J. Boertien, K. Murtomäki, P. Pereira, S. Vander Zee, A. Slomp, T. Mertsalmi, R. Levo, T. Nojonen, P. Laine, L. Paulin, P. Auvinen, V. Kaasinen, F. Scheperjans, T. van Laar (Groningen, Netherlands)

    Objective: To determine the gut microbiome composition of treatment-naïve de novo Parkinson’s disease (PD) patients. Background: Over fifteen studies have independently demonstrated gut dysbiosis in…
  • MDS Virtual Congress 2021

    Effects of Angiotensin Type 1 Receptor Antagonists on Parkinson’s Disease Progression: an exploratory study in the PPMI database

    L. Udovin, M. Otero-Losada, S. Bordet, G. Chevalier, C. Quarracino, F. Capani, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: The objective of this study is to analyze the effect of exposure to AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs)  on the clinical…
  • MDS Virtual Congress 2021

    Transcranial direct current stimulation-related changes in postural responses to perturbations are not influenced by baseline clinical characteristics in Parkinson’s disease.

    V. Beretta, R. Vitório, D. Orcioli-Silva, N. Conceição, P. Nóbrega-Sousa, M. Pereira, L. Gobbi (Rio Claro, Brazil)

    Objective: To investigate the association between clinical characteristics and transcranial direct current stimulation (tDCS)-related changes in postural responses to external perturbations in people with Parkinson’s…
  • MDS Virtual Congress 2021

    INTERLEUKIN 4 (IL-4),INTERLEUKIN 1α (IL-1α) AND CORTISOL SERUM LEVELS IN PARKINSON’S DISEASE PATIENTS UNDERGOING DANCE THERAPY

    K. Marques, J. Duarte, G. Bahia, B. Dos Santos-Lobato, L. Krejcová, C. Bahia (Belém, Brazil)

    Objective: To identify changes in anti and pro-inflammatory cytokines and cortisol hormone levels in patients with Parkinson's disease undergoing dance therapy. Background: Parkinson’s disease(PD) pathophysiology…
  • MDS Virtual Congress 2021

    Telemonitoring physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease: adherence rate, barriers to attend, safety and overall experience.

    C. Torriani-Pasin, V. Domingues, T. Freitas, T. Silva, M. Caldeira, R. Júnior, A. Lara, B. Araujo, G. Palma, M. Makhoul, L. Mochizuki (São Paulo, Brazil)

    Objective: To evaluate adherence rate, barriers to attendance, and safety of a telemonitoring physical exercise program for individuals with Parkinson’s disease (PD); To evaluate the…
  • MDS Virtual Congress 2021

    A Pandemic Care Partner Summit: Online Program Helps Parkinson’s Care Partners Take Positive Actions

    D. Perret, A. Wallis (Miami, USA)

    Objective: The Parkinson’s Foundation Care Partner Summit | Cumbre Para Cuidadores was held virtually on May 16, 2020 in the height of the COVID-19 Pandemic.…
  • MDS Virtual Congress 2021

    The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Leohrer, A. Rizos, S. Jost, A. Gronostay, A. Konitsioti, M. Barbe, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: To explore a new rating tool to assess satisfaction with life and treatment (SLTS-7) in a PD population. Background: The satisfaction with life and in…
  • MDS Virtual Congress 2021

    Subthalamic nucleus deep brain stimulation implant hemisphere differentially changes verbal fluency in patients with Parkinson disease

    V. Del Bene, D. Marotta, R. Martin, C. Gonzalez, J. Bentley, B. Guthrie, S. Black, M. Nelson, H. Walker (Birmingham, USA)

    Objective: To investigate verbal fluency following unilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with Parkinson’s disease (PD). Background: Verbal fluency declines in…
  • « Previous Page
  • 1
  • …
  • 388
  • 389
  • 390
  • 391
  • 392
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley